Stay updated on EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer
Sign up to get notified when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.

Latest updates to the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page
- Check4 days agoChange DetectedA new Revision: v3.5.4 was added to the page, and the previous Revision: v3.5.3 along with sponsor/contact lines (AstraZeneca, the Cancer Study Locator phone and email) and a 'Helpful Links Provided by' label were removed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating a site or release maintenance update rather than a change to the study record.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Naples, Italy, 80131 and removed Napoli, Italy, 80131 from the study locations.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer
Enter your email address, and we'll notify you when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.